Vivos Inc (RDGL)

[CatfishHunter]

I’d be surprised if Korenko does a blindside and announces IDE approval without announcing submission first.

I would like to see submission with a run up back to the $0.30-$0.50 range, given high probability of approval. The blindside will be when he announces approval post submission. There will be a lot of swing/flippers playing the submission run and trying to time exit before IDE approval/denial announcement.

I expect another spike post IDE approval then another settling in SP.

The unknown is how many PRs (and content) Vivos may put out post IDE approval news.

I do expect as PRs detail when clinical testing will start etc. will continue to drive SP higher with each phase. Still think uplisting will happen during clinicals.